Table 1 The sources and locations for the 38 gene expression datasets analyzed

From: pAKT pathway activation is associated with PIK3CA mutations and good prognosis in luminal breast cancer in contrast to p-mTOR pathway activation

Dataset

No. of patients

Permanent identifier

References

NKI

337

10.1038/415530a

31, 32

UCSF

162

GSE123833

33, 34

STNO2

122

GSE4335

35

NCI

99

10.1073/pnas.1732912100

36

UNC4

337

GSE18229

37

CAL

118

E-TABM-158

38

MDA4

129 (65)

GSE123832

39, 40

KOO

88

GSE123831

41

HLP

53

E-TABM-543

42

EXPO

353

GSE2109

43

VDX

344

GSE2034/GSE5327

44, 45

MSK

99

GSE2603

46

UPP

251 (190)

GSE3494

47

STK

159

GSE1456

48

UNT

137 (92)

GSE2990

36, 49

DUKE

171

GSE3143

50

TRANSBIG

198

GSE7390

51

DUKE2

160

GSE6961

52

MAINZ

200

GSE11121

53

LUND2

105

GSE5325

54

LUND

143

GSE5325

55

FNCLCC

150

GSE7017

56

EMC2

204

GSE12276

57

MUG

152

GSE10510

58

NCCS

183

GSE5364

59

MCCC

75

GSE19177

60

EORTC10994

49

GSE1561

61

DFHCC

115

GSE19615

62

DFHCC2

84 (75)

GSE18864

63

DFHCC3

40 (26)

GSE3744

64

DFHCC4

129

GSE5460

65

MAQC2

230

GSE20194

66

TAM

345 (242)

GSE6532/GSE9195

67

MDA5

298

GSE17705

68

VDX3

136

GSE12093

69

PNC

248

GSE20713

70

TCGA

517

https://tcga-data.nci.nih.gov/docs/publications/brca_2012/

26

METABRIC

1643

EGAS00000000083

14

  1. Duplicated patients were removed from few datasets for the estimation of concordance and prognostic value